Literature DB >> 16140882

Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro.

Salahuddin Ahmed1, Naizhen Wang, Bilal Bin Hafeez, Vinay K Cheruvu, Tariq M Haqqi.   

Abstract

Interleukin (IL)-1beta induces the expression of matrix metalloproteinases (MMPs) implicated in cartilage resorption and joint degradation in osteoarthritis (OA). Pomegranate fruit extract (PFE) was recently shown to exert anti-inflammatory effects in different disease models. However, no studies have been undertaken to investigate whether PFE constituents protect articular cartilage. In the present studies, OA chondrocytes or cartilage explants were pretreated with PFE and then stimulated with IL-1beta at different time points in vitro. The amounts of proteoglycan released were measured by a colorimetric assay. The expression of MMPs, phosphorylation of the inhibitor of kappaBalpha (IkappaBalpha) and mitogen-activated protein kinases (MAPKs) was determined by Western immunoblotting. Expression of mRNA was quantified by real-time PCR. MAPK enzyme activity was assayed by in vitro kinase assay. Activation of nuclear factor-kappaB (NF-kappaB) was determined by electrophoretic mobility shift assay. PFE inhibited the IL-1beta-induced proteoglycan breakdown in cartilage explants in vitro. At the cellular level, PFE (6.25-25 mg/L) inhibited the IL-1beta-induced expression of MMP-1, -3, and -13 protein in the medium (P < 0.05) and this was associated with the inhibition of mRNA expression. IL-1beta-induced phosphorylation of p38-MAPK, but not that of c-Jun-N-terminal kinase or extracellular regulated kinase, was most susceptible to inhibition by low doses of PFE, and the addition of PFE blocked the activity of p38-MAPK in a kinase activity assay. PFE also inhibited the IL-1beta-induced phosphorylation of IkappaBalpha and the DNA binding activity of the transcription factor NF-kappaB in OA chondrocytes. Taken together, these novel results indicate that PFE or compounds derived from it may inhibit cartilage degradation in OA and may also be a useful nutritive supplement for maintaining joint integrity and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140882      PMCID: PMC1315308          DOI: 10.1093/jn/135.9.2096

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  50 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 2.  Signaling transduction: target in osteoarthritis.

Authors:  Francis Berenbaum
Journal:  Curr Opin Rheumatol       Date:  2004-09       Impact factor: 5.006

3.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

4.  Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells.

Authors:  S Islam; N Islam; T Kermode; B Johnstone; H Mukhtar; R W Moskowitz; V M Goldberg; C J Malemud; T M Haqqi
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

5.  Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1).

Authors:  M P Vincenti; C I Coon; J A Mengshol; S Yocum; P Mitchell; C E Brinckerhoff
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms.

Authors:  De-Xing Hou; Keiko Kai; Jian-Jian Li; Shigang Lin; Norihiko Terahara; Mika Wakamatsu; Makoto Fujii; Mattew R Young; Nancy Colburn
Journal:  Carcinogenesis       Date:  2003-09-26       Impact factor: 4.944

7.  Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB.

Authors:  Rashmi Singh; Salahuddin Ahmed; Najmul Islam; Victor M Goldberg; Tariq M Haqqi
Journal:  Arthritis Rheum       Date:  2002-08

8.  Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells.

Authors:  Satoru Kawaii; Ephraim P Lansky
Journal:  J Med Food       Date:  2004       Impact factor: 2.786

Review 9.  Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies.

Authors:  Charles J Malemud; Najmul Islam; Tariq M Haqqi
Journal:  Cells Tissues Organs       Date:  2003       Impact factor: 2.481

10.  Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes.

Authors:  Salahuddin Ahmed; Naizhen Wang; Mathew Lalonde; Victor M Goldberg; Tariq M Haqqi
Journal:  J Pharmacol Exp Ther       Date:  2003-11-04       Impact factor: 4.030

View more
  54 in total

1.  Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.

Authors:  Aicha Saadane; Sophia Masters; Joseph DiDonato; Jingfeng Li; Melvin Berger
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

2.  Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β-stimulated SK-N-SH cells.

Authors:  Ravikanth Velagapudi; Gina Baco; Sunjeet Khela; Uchechukwu Okorji; Olumayokun Olajide
Journal:  Eur J Nutr       Date:  2015-07-10       Impact factor: 5.614

3.  Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism.

Authors:  Matthew B Rettig; David Heber; Jiabin An; Navindra P Seeram; Jian Y Rao; Huiren Liu; Tobias Klatte; Arie Belldegrun; Aune Moro; Susanne M Henning; Deqiong Mo; William J Aronson; Allan Pantuck
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

4.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

5.  Intake of Pomegranate Prevents the Onset of Osteoarthritis: Molecular Evidences.

Authors:  Zafar Rasheed
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

6.  Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells.

Authors:  S E Park; K Sapkota; S Kim; H Kim; S J Kim
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

7.  A Polyphenol-rich Pomegranate Fruit Extract Suppresses NF-κB and IL-6 Expression by Blocking the Activation of IKKβ and NIK in Primary Human Chondrocytes.

Authors:  Abdul Haseeb; Nazir M Khan; Omer S Ashruf; Tariq M Haqqi
Journal:  Phytother Res       Date:  2017-03-09       Impact factor: 5.878

8.  The antagonistic actions of endogenous interleukin-1β and 15-deoxy-Δ12,14-prostaglandin J2 regulate the temporal synthesis of matrix metalloproteinase-9 in sheared chondrocytes.

Authors:  Pu Wang; Fei Zhu; Konstantinos Konstantopoulos
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

9.  Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.

Authors:  M Ghavipour; G Sotoudeh; E Tavakoli; K Mowla; J Hasanzadeh; Z Mazloom
Journal:  Eur J Clin Nutr       Date:  2016-08-31       Impact factor: 4.016

10.  Mitochondrial dysfunction triggers a catabolic response in chondrocytes via ROS-mediated activation of the JNK/AP1 pathway.

Authors:  Mohammad Y Ansari; Nashrah Ahmad; Sriharsha Voleti; Saima J Wase; Kimberly Novak; Tariq M Haqqi
Journal:  J Cell Sci       Date:  2020-11-30       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.